Chain Bridge I (CBRG) to Combine with Phytanix Bio in $58M Deal
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once
Read More
To access this post, you must purchase 1 - User: Monthly Plan.